You are here

  • Home
  • Archive
  • Volume 9, Issue 7
  • Dosage reduction and discontinuation of biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: protocol for a pragmatic, randomised controlled trial (the BIOlogical Dose OP…

Article metrics

Article menu

Download PDFPDF

XML
Rheumatology
Protocol
Dosage reduction and discontinuation of biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: protocol for a pragmatic, randomised controlled trial (the BIOlogical Dose OPTimisation (BIODOPT) trial)

 

Online download statistics by month:

Online download statistics by month: July 2019 to April 2024

AbstractFullPdf
Jul 2019809796112
Aug 201910610142
Oct 201916015248
Nov 201917317143
Dec 201913013037
Jan 2020656517
Feb 2020898437
Mar 2020727131
May 2020454217
Jun 2020454119
Jul 2020545417
Aug 2020333221
Sep 2020737124
Oct 2020898633
Nov 2020696229
Dec 2020393727
Jan 2021302722
Feb 2021414122
Mar 2021575430
Apr 202110610037
May 2021544930
Jun 2021393918
Jul 2021373625
Aug 2021242315
Sep 2021423923
Oct 2021999444
Nov 2021312929
Dec 2021454421
Jan 2022323423
Feb 2022262812
Mar 2022383613
Apr 2022292815
May 2022464624
Jun 2022434223
Jul 2022242015
Aug 2022292617
Sep 2022474231
Oct 2022333516
Nov 2022282616
Dec 2022292611
Jan 2023313115
Feb 20231094
Mar 2023232213
Apr 2023171812
May 2023322619
Jun 2023413214
Jul 2023282713
Aug 2023262717
Sep 2023394019
Oct 2023676125
Nov 2023464116
Dec 2023423910
Jan 2024342916
Feb 2024313031
Mar 2024252582
Apr 2024131312
Total356534291404